Tianjin Medical Journal ›› 2024, Vol. 52 ›› Issue (9): 985-990.doi: 10.11958/20231667
• Applied Research • Previous Articles Next Articles
DING Peisen1(), LIU Siyu1, XING Zhilei1, YU Xiaomeng2, SONG Jiahui1, CUI Yushan3, LIU Hongliang1,△(
)
Received:
2023-11-01
Revised:
2024-01-11
Published:
2024-09-15
Online:
2024-09-06
Contact:
△E-mail:DING Peisen, LIU Siyu, XING Zhilei, YU Xiaomeng, SONG Jiahui, CUI Yushan, LIU Hongliang. Visual analysis of molecular and cellular biology of thyroid cancer based on VOSviewer[J]. Tianjin Medical Journal, 2024, 52(9): 985-990.
CLC Number:
序号 | 作者 | 机构 | 期刊 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
姓名 | 被引 量/次 | 发文 量/篇 | 篇均被 引量/次 | 机构名 | 被引量/ 次 | 发文 量/篇 | 篇均被 引量/次 | 期刊名 | 被引 量/次 | 载文量/ 篇 | 篇均被 引量/次 | |
1 | ENG C | 353 | 10 | 35.3 | 中国医科大学 | 832 | 38 | 14.1 | Oncotarget | 1 279 | 62 | 20.6 |
2 | FUSCO A | 290 | 11 | 26.4 | 复旦大学 | 786 | 41 | 19.2 | International Journal of Molecular Sciences | 705 | 35 | 12.1 |
3 | ZHANG L | 202 | 13 | 15.5 | 美国国家癌 症研究所 | 620 | 44 | 21.9 | Oncology Letters | 580 | 30 | 9.3 |
4 | HOU P | 202 | 11 | 18.4 | 上海交通大学 | 554 | 26 | 9.1 | Cancers | 508 | 42 | 20.1 |
5 | RUSSO D | 172 | 9 | 19.1 | 西安交通大学 | 466 | 23 | 13.6 | Endocrine-related Cancer | 436 | 24 | 19.3 |
6 | CHENG S P | 155 | 10 | 15.5 | 那不勒斯费德 里科二世大学 | 395 | 29 | 21.3 | Frontiers in Oncology | 392 | 20 | 9.7 |
7 | QU N | 154 | 10 | 15.4 | 纪念斯隆-凯特 琳癌症中心 | 365 | 23 | 15.9 | Endocrine | 361 | 22 | 13.1 |
8 | WANG Y | 105 | 9 | 11.7 | 中山大学 | 310 | 34 | 20.3 | Tumor Biology | 336 | 36 | 18.2 |
9 | LIU W | 100 | 9 | 11.1 | 山东大学 | 304 | 21 | 14.5 | Oncology Reports | 327 | 25 | 16.4 |
10 | CHENG S Y | 76 | 8 | 9.5 | 温州医科大学 | 178 | 21 | 8.5 | Frontiers in Endocrinology | 282 | 29 | 19.6 |
Tab.1 Authors, institutions and journals of the top 10 publications during 2013-2022
序号 | 作者 | 机构 | 期刊 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
姓名 | 被引 量/次 | 发文 量/篇 | 篇均被 引量/次 | 机构名 | 被引量/ 次 | 发文 量/篇 | 篇均被 引量/次 | 期刊名 | 被引 量/次 | 载文量/ 篇 | 篇均被 引量/次 | |
1 | ENG C | 353 | 10 | 35.3 | 中国医科大学 | 832 | 38 | 14.1 | Oncotarget | 1 279 | 62 | 20.6 |
2 | FUSCO A | 290 | 11 | 26.4 | 复旦大学 | 786 | 41 | 19.2 | International Journal of Molecular Sciences | 705 | 35 | 12.1 |
3 | ZHANG L | 202 | 13 | 15.5 | 美国国家癌 症研究所 | 620 | 44 | 21.9 | Oncology Letters | 580 | 30 | 9.3 |
4 | HOU P | 202 | 11 | 18.4 | 上海交通大学 | 554 | 26 | 9.1 | Cancers | 508 | 42 | 20.1 |
5 | RUSSO D | 172 | 9 | 19.1 | 西安交通大学 | 466 | 23 | 13.6 | Endocrine-related Cancer | 436 | 24 | 19.3 |
6 | CHENG S P | 155 | 10 | 15.5 | 那不勒斯费德 里科二世大学 | 395 | 29 | 21.3 | Frontiers in Oncology | 392 | 20 | 9.7 |
7 | QU N | 154 | 10 | 15.4 | 纪念斯隆-凯特 琳癌症中心 | 365 | 23 | 15.9 | Endocrine | 361 | 22 | 13.1 |
8 | WANG Y | 105 | 9 | 11.7 | 中山大学 | 310 | 34 | 20.3 | Tumor Biology | 336 | 36 | 18.2 |
9 | LIU W | 100 | 9 | 11.1 | 山东大学 | 304 | 21 | 14.5 | Oncology Reports | 327 | 25 | 16.4 |
10 | CHENG S Y | 76 | 8 | 9.5 | 温州医科大学 | 178 | 21 | 8.5 | Frontiers in Endocrinology | 282 | 29 | 19.6 |
序号 | 国家 | 发文量/篇 | 被引量/次 | 篇均被引量/次 |
---|---|---|---|---|
1 | 中国 | 667 | 8 081 | 12.1 |
2 | 美国 | 291 | 6 470 | 22.2 |
3 | 意大利 | 155 | 3 089 | 19.9 |
4 | 韩国 | 95 | 1 115 | 11.7 |
5 | 日本 | 78 | 1 108 | 14.2 |
6 | 德国 | 76 | 1 562 | 20.6 |
Tab.2 The top 6 countries ranked and the number of articles and articles cited during 2013-2022
序号 | 国家 | 发文量/篇 | 被引量/次 | 篇均被引量/次 |
---|---|---|---|---|
1 | 中国 | 667 | 8 081 | 12.1 |
2 | 美国 | 291 | 6 470 | 22.2 |
3 | 意大利 | 155 | 3 089 | 19.9 |
4 | 韩国 | 95 | 1 115 | 11.7 |
5 | 日本 | 78 | 1 108 | 14.2 |
6 | 德国 | 76 | 1 562 | 20.6 |
序号 | 题目 | 作者 | 共被引数 | 发表年 | 期刊 |
---|---|---|---|---|---|
1 | Molecular pathogenesis and mechanisms of thyroid cancer | XING Mingzhao | 89 | 2013 | Nature Reviews Cancer |
2 | 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer | HAUGEN Bryan R | 71 | 2016 | Thyroid |
3 | Integrated genomic characterization of papillary thyroid carcinoma | AGRAWAL Nishant | 67 | 2014 | Cell |
4 | Hallmarks of cancer: the next generation | HANAHAN Douglas | 60 | 2011 | Cell |
5 | Thyroid cancer | CABANILLAS Maria E | 58 | 2016 | The Lancet |
Tab.3 The top 5 co-cited references during 2013-2022
序号 | 题目 | 作者 | 共被引数 | 发表年 | 期刊 |
---|---|---|---|---|---|
1 | Molecular pathogenesis and mechanisms of thyroid cancer | XING Mingzhao | 89 | 2013 | Nature Reviews Cancer |
2 | 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer | HAUGEN Bryan R | 71 | 2016 | Thyroid |
3 | Integrated genomic characterization of papillary thyroid carcinoma | AGRAWAL Nishant | 67 | 2014 | Cell |
4 | Hallmarks of cancer: the next generation | HANAHAN Douglas | 60 | 2011 | Cell |
5 | Thyroid cancer | CABANILLAS Maria E | 58 | 2016 | The Lancet |
[1] | LIM H, DEVESA S S, SOSA J A, et al. Trends in thyroid cancer incidence and mortality in the United States,1974-2013[J]. JAMA, 2017, 317(13):1338-1348. doi:10.1001/jama.2017.2719. |
[2] | 董芬, 张彪, 单广良. 中国甲状腺癌的流行现状和影响因素[J]. 中国癌症杂志, 2016(1):47-52. |
DONG F, ZHANG B, SHAN G L. Distribution and risk factors of thyroid cancer in China[J]. China Oncol, 2016(1):47-52. doi:10.3969/j.issn.1007-3969.2016.01.008. | |
[3] | ENEWOLD L, ZHU K, RON E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics,1980-2005[J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(3):784-791. doi:10.1158/1055-9965.EPI-08-0960. |
[4] | XING M. Molecular pathogenesis and mechanisms of thyroid cancer[J]. Nat Rev Cancer, 2013, 13(3):184-199. doi:10.1038/nrc3431. |
[5] | QIN Y, ZHANG Q, LIU Y. Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain[J]. Brain Res Bull, 2020, 156:15-24. doi:10.1016/j.brainresbull.2019.12.004. |
[6] | 唐增煦, 高凌, 崔彦红, 等. 《卫生研究》2011—2020年高被引论文特征分析[J]. 卫生研究, 2023, 52(5):774-776. |
TANG Z X, GAO L, CUI Y H, et al. Analysis of the characteristics of highly cited papers in Health Research from 2011 to 2020[J]. J Hyg Res, 2023, 52(5):774-776. doi:10.19813/j.cnki.weishengyanjiu.2023.05.014. | |
[7] | SHEN W H, BALAJEE A S, WANG J, et al. Essential role for nuclear PTEN in maintaining chromosomal integrity[J]. Cell, 2007, 128(1):157-170. doi:10.1016/j.cell.2006.11.042. |
[8] | TAN M H, MESTER J, PETERSON C, et al. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands[J]. Am J Hum Genet, 2011, 88(1):42-56. doi:10.1016/j.ajhg.2010.11.013. |
[9] | XU D, GUO L, ZHANG S, et al. LGALS2 suppresses the progression of papillary thyroid carcinoma by regulating the PI3K/AKT pathway[J]. Gland Surg, 2022, 11(9):1518-1528. doi:10.21037/gs-22-452. |
[10] | CHEN B, LEI S, YIN X, et al. Mitochondrial respiration inhibition suppresses papillary thyroid carcinoma via PI3K/Akt/FoxO1/Cyclin D1 pathway[J]. Front Oncol, 2022,12:900444. doi:10.3389/fonc.2022.900444. |
[11] | BARÉS G, BEÀ A, HERNÁNDEZ L, et al. ENDOG impacts on tumor cell proliferation and tumor prognosis in the context of PI3K/PTEN pathway status[J]. Cancers (Basel), 2021, 13(15):3803. doi:10.3390/cancers13153803. |
[12] | ZHANG W, RUAN X, LI Y, et al. KDM1A promotes thyroid cancer progression and maintains stemness through the Wnt/β-catenin signaling pathway[J]. Theranostics, 2022, 12(4):1500-1517. doi:10.7150/thno.66142. |
[13] | THANAS C, ZIROS P G, CHARTOUMPEKIS D V, et al. The Keap1/Nrf2 signaling pathway in the thyroid-2020 update[J]. Antioxidants (Basel), 2020, 9(11):1082. doi:10.3390/antiox9111082. |
[14] | FOTH M, MCMAHON M. Autophagy inhibition in BRAF-driven cancers[J]. Cancers (Basel), 2021, 13(14):3498. doi:10.3390/cancers13143498. |
[15] | PRATT E C, ISAAC E, STATER E P, et al. Synthesis of the PET tracer (124)I-trametinib for MAPK/ERK kinase distribution and resistance monitoring[J]. J Nucl Med, 2020, 61(12):1845-1850. doi:10.2967/jnumed.120.241901. |
[16] | PIANA S, ZANETTI E, BISAGNI A, et al. Expression of NOTCH1 in thyroid cancer is mostly restricted to papillary carcinoma[J]. Endocr Connect, 2019, 8(8):1089-1096. doi:10.1530/EC-19-0303. |
[17] | KIM H J, KIM M J, KIM A, et al. The role of Notch1 signaling in anaplastic thyroid carcinoma[J]. Cancer Res Treat, 2017, 49(2):509-517. doi:10.4143/crt.2016.214. |
[18] | 崔玉山, 刘洪亮. 甲状腺癌流行病学特征和碘营养关系研究进展[J]. 环境卫生学杂志, 2020, 10(2):212-217. |
CUI Y S, LIU H L. Epidemiological characteristics of thyroid cancer and its association with iodine nutrition[J]. J Environ Hyg, 2020, 10(2):212-217. doi:10.13421/j.cnki.hjwsxzz.2020.02.023. | |
[19] | 杨绍时, 周扬, 柴慈曼, 等. 甲状腺微小乳头状癌组织学亚型的临床病理意义及与颈部淋巴结转移的关系[J]. 天津医药, 2022, 50(6):638-642. |
YANG S S, ZHOU Y, CHAI C M, et al. Clinicopathological significance of histological subtypes in papillary thyroid microcarcinoma and its correlation with cervical lymph node metastasis[J]. Tianjin Med J, 2022, 50(6):638-642. doi:10.11958/20211096. | |
[20] | DONALDSON L B, YAN F, MORGAN P F, et al. Hobnail variant of papillary thyroid carcinoma: a systematic review and Meta-analysis[J]. Endocrine, 2021, 72(1):27-39. doi:10.1007/s12020-020-02505-z. |
[21] | SCHONFELD S J, MORTON L M, BERRINGTON DE GONZÁLEZ A, et al. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States,2000-2015[J]. Cancer Epidemiol, 2020,64:101664. doi:10.1016/j.canep.2019.101664. |
[22] | JOSEPH K R, EDIRIMANNE S, ESLICK G D. The association between breast cancer and thyroid cancer: a Meta-analysis[J]. Breast Cancer Res Treat, 2015, 152(1):173-181. doi:10.1007/s10549-015-3456-6. |
[23] | MESTER J, CHARIS E. PTEN hamartoma tumor syndrome[J]. Handb Clin Neurol, 2015,132:129-137. doi:10.1016/B978-0-444-62702-5.00009-3. |
[24] | WANG X, XU S, ZHANG L, et al. Vitamin C induces ferroptosis in anaplastic thyroid cancer cells by ferritinophagy activation[J]. Biochem Biophys Res Commun, 2021, 551:46-53. doi:10.1016/j.bbrc.2021.02.126. |
[25] | QIN Y, ZHANG D, ZHANG H, et al. Construction of a ferroptosis-related five-lncRNA signature for predicting prognosis and immune response in thyroid carcinoma[J]. Cancer Cell Int, 2022, 22(1):296. doi:10.1186/s12935-022-02674-z. |
[26] | REN X, DU H, CHENG W, et al. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer[J]. Front Endocrinol (Lausanne), 2022,13:997873. doi:10.3389/fendo.2022.997873. |
[27] | SHI J, WU P, SHENG L, et al. Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma[J]. Cancer Cell Int, 2021, 21(1):669. doi:10.1186/s12935-021-02389-7. |
[28] | KUDELKA M R, LASANAJAK Y, SMITH D F, et al. Serum glycomic profile as a predictive biomarker of recurrence in patients with differentiated thyroid cancer[J]. Cancer Med, 2023, 12(6):6768-6777. doi:10.1002/cam4.5465. |
[29] | REN X, SHU J, WANG J, et al. Machine learning reveals salivary glycopatterns as potential biomarkers for the diagnosis and prognosis of papillary thyroid cancer[J]. Int J Biol Macromol, 2022, 215:280-289. doi:10.1016/j.ijbiomac.2022.05.194. |
[30] | COBO M J, LÓPEZ-HERRERA A G, HERRERA-VIEDMA E, et al. Science mapping software tools:review,analysis,and cooperative study among tools[J]. JASIST, 2011, 62(7):1382-1402. doi:10.1002/ASI.21525. |
[1] | LIU Qingqing, LI Yiqiang, SHI Yushi, LU Haisong, CHENG Weimin. Research progress on the mechanism of the TGF-β signaling pathway in myelodysplastic syndrome [J]. Tianjin Medical Journal, 2024, 52(7): 781-784. |
[2] | ZHENG Junyi, LI Xiaofeng, GUO Xukun. The protective effect and mechanism of melatonin on myocardial ischemic reperfusion injury [J]. Tianjin Medical Journal, 2023, 51(10): 1054-1058. |
[3] | YANG Shaoshi, ZHOU Yang, CHAI Ciman, SUN Ning, WANG Hong, SUN Yu△. Clinicopathological significance of histological subtypes in papillary thyroid microcarcinoma and its correlation with cervical lymph node metastasis [J]. Tianjin Medical Journal, 2022, 50(6): 638-642. |
[4] | CHENG Ran, WEI Feng△, ZHANG Yuan, LIU Meilan, HE Jia. The inhibitory effect of 5-aza-2'-deoxycytidine on xenograft tumor of human thyroid carcinoma in nude mice and its mechanism [J]. Tianjin Medical Journal, 2022, 50(5): 476-481. |
[5] | WANG Qiong, , ZHAN Jianghua△. Research progress of leptin regulation of hepatic stellate cell activation in liver fibrosis [J]. Tianjin Medical Journal, 2022, 50(1): 25-29. |
[6] | XU Wei-guo, QUAN Jiang-tao, ZHOU Juan, ZHANG Zhi-lin, LIAO Yang, CHEN Rui. The diagnostic value of miR-155 combined with ultrasound in lymph node metastasis of differentiated thyroid carcinoma [J]. Tianjin Medical Journal, 2021, 49(7): 731-735. |
[7] | WANGKang, XUWei-guo△, DONGHong-chao, JIAChun-liang, DINGMei, DONGLi-ru, SIRui-fen. Study on the correlation between the size of parathyroid adenoma and the function of parathyroid and thyroid [J]. Tianjin Medical Journal, 2021, 49(3): 305-309. |
[8] | LI Li-hua, WANG Yu-jiao, LI Jun-xiong, LI Si-yu, TANG Wan-rong, QIU Ya. Resveratrol prevents inflammation and oxidative stress response in HGFs [J]. Tianjin Medical Journal, 2021, 49(12): 1245-1249. |
[9] | LU Hai-yong, LI Chao-xi, WEN De-hui△, WANG Yi-cheng. Diagnostic values of multimodal ultrasound imaging in the differentiation of moderate and highly suspected malignant thyroid nodules [J]. Tianjin Medical Journal, 2021, 49(1): 69-73. |
[10] | WU Xiao-han, LIU Chang-le. Advances in NLRP3 inflammasome and atrial fibrillation [J]. Tianjin Medical Journal, 2019, 47(3): 329-332. |
[11] | CHEN Jian-mei , YANG Rui-rui, LIU Hong-en, LIU Hong-xin, SHI Wen-xin, LIU Jiao. The role of JAK2/STAT3 signal transduction pathway in the pathogenesis of endometriosis [J]. Tianjin Medical Journal, 2019, 47(2): 136-139. |
[12] | SHI Wu-Juan, XUE Shan-shan. Research progress in related gene of autosomal recessive cutis laxa [J]. Tianjin Medical Journal, 2018, 46(9): 1027-1032. |
[13] | BIAN Jing-qi, FENG Yue-nan, NIU Wen-ying, XIAO Hong-bin△. Advances in signal transduction pathway of platelet activation [J]. Tianjin Med J, 2018, 46(1): 99-103. |
[14] | JIA Qiang, ZHANG Chun-mei, MENG Zhao-wei, TAN Jian. Predictive value of serum midkine for metastatic lesions in thyroid cancer patients with positive thyroglobulin antibody [J]. Tianjin Medical Journal, 2017, 45(7): 739-741. |
[15] | HAO Weijing1, YU Yang1, WANG Qingsong2, ZHAO Li3, YE Yan4, DONG Li1, LI Jiansen5, MENG Xiangrui5,GAO Ming1. Establishing and identification of an immortal cell line of familial papillary thyroid carcinoma with MLH1 R217C/BRAF V600E mutations [J]. Tianjin Med J, 2016, 44(6): 657-661. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||